






































The effect of ionizing radiation (IR) on longevity was 
vigorously pursued and formulated in the late 1940s, 
through to the 1960s [1, 2]. At this time, Upton et al. [3] 
studied the accelerated aging and shortened life span in 
mice by a single large, non-lethal dose of gamma-rays 
from an atomic bomb explosion. They asked: what is 
the biological basis for the effects of radiation on 
longevity? The question remained virtually unanswered 
due to uncertainty concerning radiation’s ability to 
accelerate the normal aging process. At the time, the 
connection between radiation and aging was considered 
weak because radiation’s effects, unlike aging, appeared 
to mostly cause genetic damage and affect dividing cells 








































mental effects were almost always confined to causing 
neoplasms [4, 5].  
 
Why reconsider the relationship between radiation and 
aging? There are two main reasons explored in this 
review. Firstly, epidemiological studies, especially 
those of atomic bomb survivors, show that radiation is 
now associated with a wider spectrum of age-related 
diseases than cancer alone. Secondly, advances have 
been made in understanding the biological mechanisms 
behind the cumulative deleterious health effects 
associated with radiation and aging. 
 
In addition to reviewing some of the current knowledge 
of IR effects on aging, this work also evaluates the 
similarities and differences between hypotheses/theories  



























biomarkers  in  calorie  restriction  studies;  yet,  biomarkers  such  as  telomere  erosion  and  p16
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process. There are a few mainstream evolutionary 
hypotheses of aging that propose the manner in which 
aging arises and is inherited by species. These theories 
include: a) the accumulation of deleterious somatic 
mutations in post-mitotic cells and reduced ability to 
repair DNA [6, 7], b) antagonistic pleiotropy referring 
to genes that enhance reproductive success early in life, 
the by-product of which is later decline and death [8], 
and c) a disposable soma that says finite food energy is 
preferentially used for reproduction, but compromises 
repair [9]. 
 
The processes behind these aging hypotheses can be 
coarsely categorized either as accumulated wear and 
tear or pre-programmed senescence [10]. Although it’s 
difficult to separate out cause and effect, possible aging 





































tations and shorter telomeres (Table 1). Antioxidant 
defence, DNA repair and telomerase temper the effects 
of these deleterious mechanisms. Harman [11] in 1956 
formulated his free-radical theory of aging and later 
identified mitochondrial respiration as the major 
endogenous source of oxidative stress [12]. This 
prominent theory has particular relevance to IR as its 
health effects are derived from the free radicals 
produced in intracellular and extracellular water. 
Radiation effects are shown to exhibit many 
characteristics of cellular wear and tear such as somatic 
mutations, which can lead to the excess occurrence of 
diseases normally associated with aging, with some 
notable exceptions. It is acknowledged that much of the 
evidence relevant to radiation and aging is for high 
doses; yet this review highlights where possible the 








































Causes of aging   Physiological 
characteristics  
Aging health effects   IR health effects 







radicals [11, 12]. 
Damage to proteins 
(glycation), lipids and DNA 




Yes: Can cause DNA DSBs, 








Increased 8-oxo-dG lesions 
in mitochondrial DNA and 
decreased repair [83]. 
Cancer and 
neurodegeneration [37]. 
Yes: 8X more γ-ray oxidative 
damage to mitochondrial than 
nuclear DNA [39]. 
Rate of living   The higher the 
metabolic rate, the 
shorter the life 
span [160]. 
Oxidative damage increases 




life span [154]. 
No: Ability to change metabolic 





Shorter telomeres lead to 
replicative senescence [91, 
95]. 
Cardiovascular disease 
[98, 97]. Segmental 
aging in some progerias 
[138]. 
Ambiguous: No change in 
telomere length [102]. Short 
telomeres increase sensitivity to 
radiation [103, 105]. 


















innate and adaptive immune 
response 
(immunosenescence) and  
increased autoimmune 






No: No dose response for 
autoimmune hypothyroidism and 
rheumatoid arthritis in A-bomb 
survivors [15, 26]. Excess type 2 
diabetes only at high doses [142]. 
Ambiguous: Evidence of 
immunological decline in A-
bomb survivors [23, 53, 54], but 




Hormone levels.   Decreased naïve T-cells and 
lymphocytes [23]. 







activation of the 
TOR pathway 
[152]. 
Increased insulin resistance, 





Ambiguous: A-bomb survivors 
show high blood pressure and 
cholesterol, excess 
atherosclerosis, but no excess 
diabetes and dementia [15, 19, 
20]. 

























COMPARISON OF AGING AND RADIATION 
EFFECTS 
 
1.  Cancer and non-cancer health effects  
 
The principal effects of aging are the exponential rise in 
the incidence and mortality rates of cancer and non-
cancer diseases and the progressive increase in tissue 
degeneration and atrophy. Epidemiological studies 
show associations between IR, a mutagenic agent, and 
most forms of cancer and some non-cancer diseases. 
Cancer, cardiovascular disease, dementia and type 2 
diabetes are elevated in old age (Table 2) and usually 
result in the diminution of life span. The excess 
incidence rates of most solid cancers induced in A-
bomb survivors are mainly dependent on the attained 
age, rather than the age at exposure or age since 
exposure [13]. The A-bomb data is important to 
radiation protection practices as the survivors generally 
experienced an acute exposure at relatively low doses, 
with over 60% receiving doses less than 100 mSv (or 
100 mGy) [14]. There is a statistically significant linear 
dose response for the solid cancer risk from 0-3 Sv, 
even when restricting the analysis to the 0-125 mSv 
dose range [15, 16]. The ratio of non-cancer to solid 
cancer excess deaths is about 0.63. Therefore, risk 
coefficients for mortality arising from excess leukae-



























Age-related biological effects  Radiation induced? 
Arthritis  No: Hormetic low dose treatment [58].
Apoptosis  Yes: Cell killing dose response seen in A-bomb survivors [14, 16]. 
Autoimmune diseases  No: Rheumatoid arthritis and autoimmune thyroiditis are not in excess for A-bomb survivors 
[26].  
Cancers  Yes: A-bomb survivors and radiotherapy induce excess leukaemia [164] and solid cancers [15].   
Cardiovascular disease and 
stroke 
Yes: Excess heart disease and stroke in A-bomb survivors [15]; also heart disease risk in nuclear 
industry workers [165]. 
Cataracts  Yes: Elevated in A-bomb survivors [21], aviation crews and astronauts [22]. 
Chronic inflammation  Ambiguous: Yes, in A-bomb survivors [53, 54]. No, as hormetic anti-inflammatory effect [58]. 
Infectious disease  Ambiguous: No, excess infectious disease in A-bomb survivors is not significant [29, 30]. Yes, 
lower prevalence of hepatitis C virus but more chronic liver disease [27, 28]. Yes, as dose-
dependent reduction in T-cells, 10% per Gy [24]. 
Neurological disorders, 
including dementia 
Ambiguous: No, excess dementia in A-bomb survivors [15, 143]. Yes, as dementia or cognitive 
impairment caused by radiotherapy of the head [144]. 
Osteoporosis  Ambiguous: Yes, induced in animals [31]. No increase for A-bomb survivors [15].
Physiological effects/diseases  Ambiguous: No, as no loss of hearing, skin elasticity, and hair greying in A-bomb survivors 
[33, 35]. Yes, for skin elasticity, hair greying [34], digestive diseases and respiratory diseases 
[15]. 
Shortened life span  Yes: Life spans shortened for American radiologists, radium dial painters, Thorotrast patients 
and A-bomb survivors [35, 136, 137]. 






3.0 and 4.8 % per Sv based on the International 
Commission on Radiological Protection’s [17] nominal 
risk coefficient for stochastic effects after exposure to 
radiation at low dose rate.  
 
Positive associations between IR and cardiovascular 
disease have been reported for radiotherapy patients and 
various radiation workers, but not at population 
radiation background levels [18]. Preston et al. [15] 
studied the mortality of A-bomb survivors occurring 
from 1950-1997. For the broad categories of heart 
disease, stroke, digestive diseases and respiratory 
diseases, there was strong evidence of a graded dose 
response for doses exceeding 500 mSv. In addition, 
precursor pathological effects, including high blood 
pressure and serum cholesterol levels, were found to be 
radiation-related, especially in females [19, 20]. 
 
Radiation-induced cataracts are generally considered to 
be a classical late deterministic effect exhibiting a dose 
threshold upon which the severity increases with dose. 
Neriishi et al. [21] conducted ophthalmologic 
examinations 55 years after the Japanese atomic 
bombings. In contradiction to earlier studies, a low or 
absent dose threshold for radiation-induced cataracts 
was seen in survivors. Similarly, preliminarily studies 
showed either an earlier age of onset or a higher 
prevalence of senile cataracts in aviation crews and 
 
 
www.impactaging.com                  889                                  AGING, November 2009, Vol.1 No.11astronauts exposed to cosmic radiation [22].  
 
Evidence is emerging that the immune systems of A-
bomb survivors were damaged in proportion to 
irradiation that they were exposed to in 1945 [23]. Long 
after exposure, a declining naïve T-cell pool was found to 
be associated with both radiation and aging [24]. 
Kusunoki and Hayashi [23] proposed that radiation 
accelerated the natural processes associated with 
immunological aging. Nagataki et al. [25] were the first 
to demonstrate a significant increase in the autoimmune 
disease, antibody-positive spontaneous hypothyroidism, 
among atomic bomb survivors. However, a later study of 
A-bomb survivors, 55-58 years after radiation exposure, 
found excess malignant and benign thyroid nodules, but 
no significant dose response for autoimmune thyroid 
diseases [26]. When hepatitis C virus is present, radiation 
can enhance the progress of liver disease and liver cancer 
[27,  28]. The general occurrence of infectious disease, 
urinary diseases and pneumonia are not significantly 
correlated to radiation dose in A-bomb survivors, 
although the risks  of the latter two illnesses are elevated 
and suggestive of bias [29, 30]. 
 
A-bomb survivors show a lack of significant excess 
mortality for some common age-related diseases, such 
as type 2 diabetes, infectious disease and Alzheimer’s 
disease [15]. This result is unexpected especially due to 
the latter two diseases being associated with oxidative 
stress and inflammation, both characteristics of 
radiation exposure. The A-bomb data collected is 
mainly concerned with cause of death or tumor 
incidence, and hence information on whether radiation 
is associated with excess non-cancer incidences is not 
available. No excess osteoporosis has been reported in 
A-bomb survivors; nevertheless, there is concern for 
astronauts subjected to complex cosmic and solar 
radiation sources (see Section 5) [31].  
 
Strehler [4] notes that for a range of human functional 
capacities and physiological measurements – e.g. 
glomerular filtration rate and maximal breathing capacity 
– there is a fall of 5% to 13% per decade beyond the age 
of thirty. Loss of skin elasticity is another physiological 
aging factor, but also precedes erythema during high dose 
radiotherapy [32]. Analysis of early A-bomb data by 
Hollingsworth et al. [33] showed no dose response for 
physiological markers of aging such as greying hair and 
skin elasticity, although these negative associations were 
contradicted by a later study [34, 35]. As of 2007, about 
40% of the A-bomb survivors were still living. It is likely 
that as more data becomes available the future trend of 
the excess cancer and noncancer incidence will continue 
to increasingly match in form, if not in frequency, that of 
the aging-associated spectrum of degenerative conditions. 
2.  Oxidative stress, antioxidants and inflammation 
  
Reactive oxygen species (ROS) and its nitrogen-equiva- 
lent (RNS) are the main sources of free radical damage. 
IR produces ROS and RNS in the presence of the 
respective gases. ROS include superoxide anion (O2
•-), 
hydrogen peroxide (H2O2), and the hydroxyl radical 
(OH
•). Reactive nitrogen species include nitric oxide 
(NO) and peroxynitrite (ONOO
–). ROS are by-products 
of neutrophils’ and macrophages’ contribution to an 
inflammatory response and of mitochondrial respiration 
[36]. ROS/RNS attack macromolecules causing 
oxidative stress, a process involved in the etiology of 
many diseases, and even at low levels in some organs 
such as the brain probably contributes to aging [37]. In 
general, increased endogenous ROS cellular levels, and 
elevated oxidative damage to DNA such as 8-
hydroxydeoxyguanosine (8-oxo-dG), parallel the aging 
process [38]. Normal oxidative lesions like 8-oxo-dG 
occur at 16-fold higher levels in mitochondrial DNA 
than in nuclear DNA of rat liver, lending support to the 
mitochondria being the cell’s Achilles heel in the aging 
process [39]. 
 
Although it is generally acknowledged that antioxidant 
defenses decline with age, the results of human and 
animal studies are somewhat variable. Blood 
glutathione levels measured in healthy aging adults, 60 
to 79 years old, were 17% lower than those of subjects 
four decades younger [40]. In human skin fibroblasts, 
the detrimental effect of ROS is enhanced in old age by 
decreased levels of antioxidant enzymes such as 
glutathione peroxidase, Cu/Zn superoxide dismutase 
(SOD) and catalase present in the cytosol or cell 
nucleus [38]. Similarly, there may be a mild reduction 
after 65 years of age for the manganese form, Mn-SOD, 
in mitochondria. However, detailed studies in animals 
show age-dependent changes in antioxidant enzymes to 
be variable, depending on the tissue or cellular 
component analyzed [41, 42]. Where antioxidant levels 
are elevated in the aged, this could be in response to a 
greater oxidant attack in senescent tissues/organelles 
requiring a higher antioxidant defense.  
 
Increased oxidative stress in old age modifies lipids, 
proteins and nuclear DNA [43,  44,  45]. There are 
contradictory results in animals [46], but in humans the 
emerging evidence is for a positive association between 
age and lipid perioxidation, including that of 
membranes [47].  Studies show an exponential rise in 
the oxidative damage to proteins with age [48]. 
Advanced glycation end-products (AGES) contribute to 
protein-cross linking found in cataracts,  atherosclerosis 
and Alzheimer’s plaques. The generation of oxidative 
stress, somatic DNA mutations and genetic instability 
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atherosclerosis, lending credence to potential inductance 
by IR [49]. Some protection is afforded against the 
detrimental effects of IR by the “oxygen effect” which 
increases radio-resistance in diseased and hypoxic 
artery walls (see Section 5) [50]. 
 
IR can promote the characteristics of aging in tissues, 
such as increased inflammation and fibrosis that are also 
components of diseases such as atherosclerosis and 
arthritis. Aging and senescent fibroblasts secrete pro-
inflammatory cytokines such as TNF-α, interleukin-1β 
(IL-1β) and IL-6, higher levels of which are found in 
cells from healthy, elderly people [51]. After exposure 
to a high dose (10 Gy) of gamma-rays, human 
endothelial cells in vitro produced enhanced levels of 
IL-6 and IL-8 (but not TNF-α) [52]. Furthermore, 
inflammation markers TNF-α, IL-6 and IL-10 
significantly increase with both radiation dose and age 
in A-bomb survivors [53,  54]. Hayashi et al. [54] 
converted these radiation effects and others, including 
total ROS, to acceleration of aging. One Gy of atomic 
radiation corresponds to a nine year increase in aging. 
Greater apoptosis, inflammation, fibrosis and the slower 
healing of damaged tissues are also well documented at 
radiation therapy levels [55]. 
 
IR and the inflammatory response are both associated 
with elevated ROS levels in tissues. Heissig et al. [56] 
showed that exposure of mice to a 2 Gy dose promotes 
mast cell recruitment and tissue revascularization in the 
short term. Rats receiving a high dose of 20 Gy to the 
abdomen recruited neutrophils into the post-irradiated 
tissue early in the inflammatory response [57]. 
Therefore, IR can be an indirect source of ROS and 
subsequent tissue injury, due to phagocytic neutrophils 
producing free radicals to ingest microorganisms or 
particles. However, for total doses between 1 and 6 Gy, 
low linear-energy-transfer (LET) X-rays can induce the 
opposite effect, invoking anti-inflammatory activity 
[58]. This hormetic effect of radiation is employed for 
the fractionated radiation therapy of insertion tendonitis 
and osteoarthritis. 
 
This begs the question, what biologically differentiates 
these contrary inflammatory responses from radiation-
mediated ROS? Moderate and high doses of IR are 
capable of cell killing, stimulating pro-inflammatory 
cytokine production, fibrosis and atherosclerosis; yet, 
low dose radiotherapy is still practiced to treat benign 
diseases. The radiobiological mechanisms under 
consideration are that multiple, small acute X-ray doses 
(or a low dose rate, chronic exposure), compared to 
high doses, provoke different stress-inducible signaling 
pathways and invoke an adaptive response that up-
regulates antioxidation and repair [59, 60].   
  
3. Apoptosis, DNA aberrations and genomic 
instability  
 
This section addresses apoptosis and the accumulation 
of deleterious somatic mutations to DNA through aging 
and compares them with those induced by radiation. 
The TP53 gene in normal cells controls the cell cycle by 
preventing cells with damaged DNA from dividing and 
also by activating DNA repair or cell death. DNA 
damage if unrepaired can lead to genetic instability that 
has been claimed to drive a multistep process leading to 
cancer. Mutations within the p53-signalling pathway are 
particularly important since they are present in more 
than 80% of all human cancers.  
 
The tumor suppressor p53 protein has been implicated 
as a paradoxical regulator of longevity and aging [61]. 
Indeed, p53 enhances survival at a young age by 
decreasing aging-associated oxidative damage and 
preventing cancer cell development [62]. Japanese A-
bomb survivors exhibit a linear dose response for solid 
cancers up to about 3 Gy; at higher doses 
transformation is significantly reduced by cell killing 
[16]. Yet, p53 appears to suppress longevity by 
preventing stem cell renewal [63] and increasing 
spontaneous apoptosis in aging post-mitotic tissues 
[64, 65]. The apoptosis of muscle cells in sarcopenia 
and neuronal loss in neurological disorders are 
implicated in these non-malignant illnesses that are 
commonly involved in the death of the very old. 
 
An experiment in mice by Feng et al. [66] showed that 
the p53 response to gamma-radiation (5 Gy) becomes 
less efficient in old age. In response to stress, the 
declining fidelity with age of p53-mediated apoptosis, 
senescence, and presumably autophagy [67], suggests 
that cell injury is accumulated not only due to less DNA 
repairs but also by reason of the less efficient removal 
of damaged protein, DNA and organelles in older 
individuals. This could be a factor in the exponential 
rise of spontaneous neoplasms and non-malignant 
illnesses in the elderly, and the elevated fraction of the 
remaining life lost observed in aged animals subjected 
to high dose irradiation [2, 68].  
 
Cancer cells contain a modified genome and 
chromosomal aberrations at frequencies greater than 
normal tissues [69] with mutations of the TP53 gene 
encoding the p53 tumor suppressor protein playing a key 
role.  There is general agreement that the most likely 
primary mechanism for radiation-induced cancer is by 
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inactivation of a particular tumor suppressor gene [17]. 
Liver cancer is the most prevalent cancer of Thorotrast 
patients exposed to alpha-particles, a form of high-linear 
energy transfer (LET) radiation. Analyses of TP53 point 
mutations and loss-of-heterozygosity (LOH) at the 17p 
locus were performed on liver tumors by Ishikawa et al. 
[70]. The LOH due to large deletions expected for direct 
action by alpha particles was infrequent, whereas point 
mutations associated with the indirect effects of aging 
were more common. 
 
Both stable (translocations, deletions and insertions) 
and the less common, unstable (dicentrics and 
fragments) chromosomal aberrations spontaneously 
accumulate with age. Spontaneous, somatic gene 
mutations such as in the HPRT locus increase 
exponentially with age in human kidney epithelia [71]. 
Vorobtsova et al. [72] studied a control group and two 
irradiated populations from aged 3 to 72 years old. 
Individuals exposed to low doses of IR, derived from 
the Chernobyl accident and atomic bomb testing, 
exhibited acceleration of the age-related increase of 
stable-chromosome aberrations, but not unstable-
chromosome aberrations, in cultured lymphocytes. 
Translocations increased with the square of the age in 
both the control and irradiated groups. The 
quantification of dicentrics in cultured, peripheral 
lymphocytes at first mitosis is the preferred 'biological 
dosimeter' for radiation exposures [73]. Although there 
is inconsistency in the age-dependent trends for 
background dicentrics [74], some studies including that 
of Ramsey et al. [75], show an increasing frequency of 
aberrations from the newborn to the very old.  
 
Genomic instability refers to damage transmitted to cells 
after many generations and can be quantified by the 
number of chromosome alterations, gene mutations or 
even cell deaths. The prevailing view is that radiation- or 
spontaneously-induced genomic instability plays a major 
role in multi-stage carcinogenesis and the functional 
decline of tissues in aging [76]. There is good evidence 
from animal and human studies to show that high-LET 
alpha-emitters such as plutonium and Thorotrast induce 
genomic instability, the latter through the inactivation of 
DNA mismatch repair [77, 78]. Surprisingly, low LET 
gamma-radiation may not have the same effect [77], as 
clonally expanded T lymphocytes from A-bomb 
survivors show no clear evidence of either stable or 
unstable chromosome instability [79, 80]. 
 
There are significant differences in the DNA damage, 
and probably the aging processes of IR, UV and 
chemical oxidants. Mitochondrial respiratory functions, 
as identified by the genes activated in yeast, are 
particularly sensitive to hydrogen peroxide, H2O2. 
Dismutation of the superoxide anion by SOD enzymes 
produces H2O2, which causes DNA base damage and 
single strand breaks (SSBs), but few double strand 
breaks (DSBs) [81]. The daily spontaneous production 
of oxidative damage (~90% from mitochondrial 
respiration and proton leakage [12]) in mammalian cells 
is substantial, as is the consequential repair of nuclear 
and mitochondrial DNA bases [82, 83]. The estimate, 
published in the 7
th Biological Effects of Ionizing 
Radiation report (BEIR VII) by the National Research 
Council [16], is that around 10200-12100 DNA bases 
daily are damaged: either depurinated, oxidized or 
deaminated. For comparison, 5.5 years of low-LET 
natural background IR at the global average, 
corresponding to 1 electron track per cell, produces only 
2.5-5 damaged bases, 2.5-5.0 SSBs and most notably 
0.25 DSBs. IR, more than endogenous H2O2, has the 
capability to produce DSBs that are more relevant to the 
aging process than SSBs [81]. In addition, high-LET 
radiation, such as alpha particles, produces clustered 
lesions that are more difficult to repair, compared to 
low-LET X-rays and gamma-rays [84]. 
 
The base excision repair pathway processes most IR 
damage in DNA, with nucleotide excision repair, DSB 
repair and mismatch repair having lesser roles [85]. An 
age-associated decline in nucleotide excision repair has 
been demonstrated by UV irradiation of human dermal 
fibroblast cultures [86]. For 
137Cs gamma-rays, 
protective cell cycle checkpoints were prevalent after 
budding yeast was exposed to a very high 200 Gy dose 
[87]; but unexpectedly this exposure did not cause an 
over expression of DNA repair enzymes in the 
surviving cells. DSBs detected in the form of DNA 
damage foci γ-H2AX and/or 53BP1 accumulate in 
various tissues of irradiated or aging mice and primates, 
likely inducing a senescent phenotype [88,  89]. 
Erroneous rejoining of DSBs can lead to genetic 
instability, tumorogenesis and age-related degeneration 
in various tissues. To conclude, both IR and aging 
enhance DNA damage, with chromosome breaks being 
particularly difficult to restore. Diminished repair of 
DNA and genomic instability, however, are more the 
consequence of aging and high-LET radiation than low-
LET radiation. 
 
4. Telomeres role in stress and replicative aging 
 
Hayflick and Moorhead [90] reported that fibroblasts in 
vitro had a limited life span, which is likely the result of 
numerous cell replications. To explain this 
phenomenon, Harley [91] proposed the telomere 
hypothesis of aging, where, despite telomerase 
expression, the repetitive DNA at the end of 
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fibroblasts, lymphocytes, and hematopoietic stem cells 
(HSCs) [92]. The enzyme telomerase adds specific 
DNA sequence repeats that were lost through cell 
division. The telomere’s role in cellular senescence was 
initially viewed as a pre-programmed ‘mitotic clock’ 
(Table 1). An alternative position is that oxidative stress 
accelerates erosion of the telomeres and induces 
replicative senescence (irreversible growth arrest) as a 
pleiotropic trait in response to mutation risk [93, 94].  
 
Stress-dependent or age-dependent telomere erosion 
itself leads to genomic instability and a dramatic 
increase in mutations. This ambivalence fuels debate 
about whether telomere shortening is a cause of aging, 
perhaps in concert with other mechanisms, or just a 
consequence. Telomeres have been reported to shorten 
in the liver, renal cortex, spleen and digestive tract 
mucosa (but not in cerebral cortex and myocardium) of 
human subjects ranging in age from neonates to 
centenarians [95]. Cawthon et al. [96] showed that there 
is a higher mortality rate, especially from heart disease 
(3.2-fold) and infectious disease (8.5-fold), among 
normal individuals 60 years or older that have shorter 
telomeres in blood DNA. This result and a recent study 
by Epel et al. [97] both lend credence to the hypothesis 
that shortened telomeres and also the rate of shortening 
can contribute to the mortality of age-related diseases 
such as cardiovascular disease [98]. Doubts about the 
telomere’s role in instigating aging arose from 
experiments such as that by Martin-Ruiz et al. [99], 
which measured the telomere length in white blood cells 
and found no association with mortality for those 
individuals 85 years old and over. However, most 
patients with dyskeratosis congenita have a defect in the 
DKC1 gene that affects telomere maintenance, resulting 
in abnormally short telomeres. This disease appears to 
link short telomeres with some signs of premature aging 
as patients suffer from early cancers, but mostly die 
young (median age 16 years) from bone marrow failure 
[100]. 
 
There is limited and equivocal information available on 
the change in telomere length induced by IR. Hande et 
al. [101] X-rayed primary mouse cells (splenocytes) and 
found increased telomerase activity and lengthened 
telomeres, both possibly involved in chromosome 
healing. Sgura et al. [102] reported on the irradiation of 
human fibroblasts and found there was no difference in 
telomere length after low-LET X-ray treatment, whereas 
high-LET protons caused a significant increase in 
length. Goytisolo et al. [103] carried out experiments 
using engineered cell lines obtained from telomerase-
deficient mice with telomeres 40% shorter than those of 
wild-type mice. The results of their animal study, which 
were later confirmed with normal human fibroblasts 
[104], provided unequivocal evidence that short 
(presumably near-dysfunctional) telomeres increase 
sensitivity to radiation. A similar result was observed in 
radiotherapy patients, as those individuals with shorter 
telomeres were more likely to develop a second cancer 
[105]. Nevertheless, there was no significant change 
when comparing telomere length before and 5 years 
after treatment. Therefore, the sparse data available 
mostly denies the actuality of radiation-mediated 
telomere erosion, a biomarker of aging further explored 
in the Discussion. 
 
5. Stem cells, senescence of bone marrow, and the 
induction of hematopoietic neoplasms 
 
The two major types of multipotent stem cells found in 
marrow are first, HSCs that produce blood/immune 
cells and second, MSCs, that normally form bone (from 
osteoblasts), cartilage, fat and stromal cells. HSCs, and 
perhaps MSCs, frequent the low oxygen environment of 
the marrow’s endosteal layer in order to keep the stem 
cells in a protective environment and quiescent state, 
and also to preserve their ability to repopulate the 
marrow [106, 107]. Cancer may be thought as a stem-
cell disease: this concept is strongest for leukemia, but 
there is increasing evidence supporting a hierarchical 
organization of cells within diverse solid cancers [108].  
 
Low oxygen tension was found to extend the life span 
and attenuate differentiation of HSCs [109]. Stem cells 
or cancer stem cells sequestered away in hypoxic stem 
cell niches and the central part of a tumor mass are less 
susceptible to ROS damage due to the “oxygen effect”, 
regardless of whether the ROS originated from 
endogenous mitochondrial respiration or exogenous 
radiotherapy [110]. Conversely, stem/progenitor cells 
occupying a well oxygenated vascular niche or 
undergoing angiogenesis or bone remodeling are more 
susceptible to radiation-induced cancers and replicative 
aging [107].  
 
As the hematopoietic system ages, the immune function 
deteriorates, the lymphoid potential diminishes, and the 
incidence of myeloid leukemia increases [111]. Aging 
leads to increased stem cell dysfunction, and as a result 
leukemia can develop in failed attempts by the marrow 
to return to a homeostatic condition after stress or 
injury. Stem cells leave the hibernation state and 
undergo self-renewal and expansion to prevent 
premature HSC exhaustion under conditions of 
hematopoietic stress [112]. HSCs in older mice produce 
a decreased number of progenitors per cell, decreased 
self-renewal and increased apoptosis with stress [113]. 
The remaining stem cells divided more rapidly as if to 
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stem cells to grow more rapidly, perhaps by stress such 
as IR, puts stem cells at greater risk of becoming cancer 
cells because of acquired DNA damage.  
 
Metabolically active senescent cells, identified by the 
biomarkers of cellular aging, such as the γ-H2AX foci 
and perhaps the β-galactosidase (SA-β-gal) enzyme, 
accumulate in aging primates [88]. Cellular senescence 
can be induced in one of two ways. Firstly, ROS may 
contribute to the plentiful SSBs and DSBs present in 
senescent cells [89]; this is a form of telomere-
independent stress-induced senescence. Alternatively, 
telomere-dependent uncapping of telomere DNA causes 
replicative senescence. An increase in oxidative stress is 
a more probable cause of HSC senescence than 
telomere erosion [114]. High doses of IR lead to 
apoptosis of HSCs, while lower doses cause HSCs to 
senesce and lose the ability to clone themselves [115]. 
Furthermore, irradiated normal human fibroblasts and 
tumor cell lines can also lose their clonogenic potential 
and undergo accelerated senescence [116]. The 
inhibition of tumorigenesis by cellular senescence is 
oncogene-induced and linked to increased expression of 
tumor suppressor genes p16
INK4a and TP53 via the DNA 
damage response [117]. Recent research points to the 
p16
INK4a protein being an important aging biomarker as 
its concentrations in peripheral blood exponentially 
increase with chronological age, reducing stem cell self-
renewal [118]. The few articles published to date 
linking radiation’s health effects and p16
INK4a can be 
paradoxical with regard to aging. A Chinese study 
showed the cumulative radiation dose of radon gas 
among uranium miners to be positively associated with 




genes in sputum, perhaps indicating early DNA damage 
and a greater susceptibility to lung cancer [119]. 
 
The number and proliferation potential of stem cell 
populations, including those of the intestinal crypt and 
muscle, decrease with age, leading to a progressive 
deterioration of tissue and organ maintenance and 
function [120, 121]. Macromolecular damage in general 
and DNA damage in particular, accumulate in HSCs 
with age [122]. The reduced ability to repair DNA 
DSBs leads to a progressive loss of HSCs and bone 
marrow cellularity during aging [123] and probably by 
irradiation. A reduction in marrow cellularity is caused 
by normal aging, but also by a high radiation dose 
(>12.5 Gy) from 
45Ca, a bone-seeking beta-ray emitter 
[124]. Excess blood diseases, including anemia and 
myelodisplastic syndrome (a precursor of acute 
myelogenous leukemia), are the most elevated 
noncancer diseases in A-bomb survivors [29]. 
Irradiation of marrow can have an adverse effect on 
bone remodeling. For example, mice exposed to 
gamma-rays, protons, carbon nuclei and other cosmic 
radiation types experienced a loss of trabecular bone 
volume ranging from 29% to 39% for doses of 2 Gy 
[31]. This result provides evidence that the bone loss in 
astronauts due to reduced gravity can be exacerbated by 
space radiation. 
 
Osteosarcoma, an osteoblastic neoplasm, is the most 
common form of spontaneous and radiation-induced 
bone cancer in a population, and especially prevalent in 
children. Female U.S. radium-dial painters were first 
exposed to 
226,228Ra at 20±5 years of age; and bone 
sarcomas appeared on average 27±14 years later [125]. 
The higher the radium activity (and dose), beyond a 
threshold value of 2 MBq, the shorter the latent period 
[126]. At low doses, the radiation-induced aging effect 
and the reduction in the latent period (from exposure to 
the cancer’s appearance) are small. Obviously, a cancer 
is not induced when the latent period remains greater 
than the human life span. In patients treated for 
tuberculosis and other diseases by a preparation 
containing
 224Ra, the incidence of bone sarcoma was 
markedly higher the younger the age of injection, being 
about 14-fold more in 1 to 5 year olds compared to 
adults more than 20 years of age [127]. In sum, high 
LET alpha particle irradiation (much more than low 
LET gamma/beta radiation) of the skeleton appears to 
induce premature aging of the bone marrow; this 
probably occurs through depletion of its stem cells, 
increased mutations of DNA, and perhaps replicative 
senescence within the remainder of the marrow stem 
cells.   
 
6.  Life shortening and life lengthening 
 
There is limited good quality experimental research that 
shows low-dose radiation-induced changes in the 
longevity of animals and especially of humans. The 
percentage of life span shortened was found to be 
relatively large in mice which were susceptible to 
developing lymphoma and leukemia after relatively 
short latent periods following radiation exposure [16]. 
Radiation life shortening occurs to a lesser degree in 
humans and some animals such as dogs that are mostly 
susceptible to solid tumors with long latent periods. A 
linear dose response for life shortening in mice of ~4 
days per Gy is common, with long protracted low-LET 
exposures five to ten times less effective than a single 
acute exposure. BEIR VII [16] cautioned that high rates 
of infectious diseases might complicate early life 
lengthening experiments, compared with later studies 
where animals were reared under specific pathogen-free 
conditions. Recent results of radiation-induced life span 
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extended by about 23% when Caratero et al. [128] 
exposed them to continuous gamma-irradiation at dose 
rates of 70 or 140 mGy per year. However, in most 
cases it appears, unlike in calorie restriction (CR) 
studies in animals, that the maximum life span remained 
unchanged. Epidemiological studies that show radiation 
produces a hormetic effect in humans are rare. A small 
case-control study by Thompson et al. [129] found a 
marked reduction in lung cancer risk at relatively low 
radon levels, 50-123 Bq m
-3, relative to residents 
exposed to 0-25 Bq m
-3. This raises an important 
question. If IR promotes life span extension, could the 
mechanism involve an adaptive response to stress which 
allows cells or organisms to better resist the damaging 
effects of genotoxic agents by a prior exposure at a 
lower dose [59, 130]? Heat shock proteins are generated 
by low levels of oxidants such as H2O2 , superoxide 
anions  and IR, but are also elevated in rats subjected to 
a lifelong low calorie diet (see Discussion), which is 
known for its life span enhancing properties [131]. 
 
Tanaka et al. [132] gamma-irradiated male and female 
groups of mice for about 400 days at various low dose 
rates, including 1.1 and 0.05 mGy per day. Shortened 
life spans occurred only in the female mice irradiated at 
1.1 mGy per day (there was no life span change in the 
other groups irradiated at 1.1 and 0.05 mGy per day) 
compared to controls; this life-shortening was attributed 
to premature aging as there was no increased incidence 
of tumors. Albeit at high doses (3 – 8.3 Gy), radiation 
life shortening was more pronounced in mice irradiated 
early in life compared to mice irradiated at an older age 
[68]. Notwithstanding, there is an increase in the 
fraction of the remaining life that is lost due to 
irradiation as a function of the age at irradiation. Factors 
relating to the fractional effect could be due to the age-
associated increase in tumor suppressors, the decrease 
in antioxidants and DNA repair, or perhaps the age-
related depletion of the number of stem cells and the 
shortened telomere lengths of the remainder. Human 
fibroblasts irradiated in vitro with a weak gamma-ray 
dose of 1 mGy did not exhibit life shortening, while 
fibroblasts exposed to high-LET carbon ions found in 
space experienced early cell senescence at a similar 
dose [133]. However, mice exposed to carbon ions 
exhibited a relative biological effectiveness (RBE) for 
senescence of 1.4, which is little different from a RBE 
of unity for gamma-rays [134]. Nevertheless, cosmic 
radiation is considered a hazard to astronauts with the 
potential to cause life shortening and increased genomic 
instability over many generations. 
 
Current international radiation protection limits are 
based solely on mortality from excess cancers [17]. An 
alternative regulatory criterion is the ‘mean loss of life 
expectancy’ for cancers and non-cancer diseases. Some 
evidence of life shortening, independent of a 
tumorigenic effect, has been reported among American 
radiologists and radium dial painters [35]. BEIR VII 
[16] considers that life shortening at low doses is almost 
entirely due to radiation-induced cancer. The 
International Commission on Radiological Protection 
[135] estimated the loss of life expectancy from cancers 
of bone marrow as 31 years, breast cancer as 18 years 
and ovary cancers as 17 years. On average, 15 years is 
the loss of life for the fatal excess cancers occurring in a 
population irradiated over the whole body. The life span 
of German patients administered the radiographic 
contrast agent Thorotrast and irradiated with non-
uniform, high-dose, high-LET 
232Th alpha-radiation, 
was markedly shorter (about 18 years, p<0.001) than 
that of controls [136].  Premature aging may have 
occurred, as cancer had minimal effect on reducing 
patients’ life spans. Cologne and Preston [137] showed 
that life shortening also occurred in A-bomb survivors. 
Their median life expectancy decreased with increasing 
radiation dose at a rate of about 1.3 years per Gy (3 
days life lost for the mean annual US population 
exposure of 6 mSv, if a linear dose response), but 
declined more rapidly at high doses of more than ~1 Gy. 
More than 70% of the life lost was due to cancer. 
Finally, these studies and others [30] clearly 
demonstrate that when humans are irradiated their life 
expectancy is generally reduced, although the 
contribution to premature aging from factors other than 




The effects of IR and its biological mechanisms are 
similar to those seen in inherited progeroid syndromes 
and bear a resemblance to premature natural aging. 
Segmental progerias, such as dyskeratosis congenita, 
Werner’s disease, Bloom syndrome and ataxia telangiec-
tasia (AT), display some (segmental) symptoms of 
“accelerated aging”, mainly due to reduced DNA repair 
and increased genetic instability. Hofer et al. [138] 
hypothesized that only some progerias display symptoms 
– such as alopecia (baldness), osteoporosis and fingernail 
atrophy – associated with shortened telomeres, while 
other progeroid syndromes (i.e., Bloom syndrome) did 
not.  Animals that lack the AT protein, which activates a 
cell-cycle checkpoint in response to oxidative stress, have 
reduced self-renewal of HSCs [139]. Cell lines from 
radiosensitive patients with AT, Fanconi anemia and 
other diseases showed accelerated telomere shortening 
and replicative senescence upon irradiation [140]. 
Perhaps radiation workers should be genetically 
screened, as AT heterozygotes are mildly radiation 
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Like progerias, irradiation at high doses induces 
segmental aging. Alzheimer’s disease, H. pylori 
infection, diabetes and arthritis are all associated with 
increased oxidative stress on the basis of biomarkers of 
oxidative damage [141]. It is not unreasonable to expect 
radiation to increase the incidence of these diseases as it 
induces oxidative stress in tissue. Yet notably absent in 
the statistically significant cause of excess deaths 
among A-bomb survivors are type 2 diabetes (except in 
high dose group 2.3±0.8 Gy), infectious disease and 
dementia (including Alzheimer’s disease) 
[15, 142, 143]. Nevertheless, high dose radiotherapy of 
the brain can result in cognitive impairment and 
dementia [144]. The spectrum and occurrence of the 
spontaneous cancers of old age are different from those 
induced by radiation. Most cancer types are observed in 
excess in A-bomb survivors, the important exceptions 
being chronic lymphocytic leukaemia (CLL), 
pancreatic, prostate and uterine cancers [15,  30]. The 
association of prostate cancer with the radiation 
exposure of nuclear workers is non-existent or weak 
[145]. CLL was generally considered to be a prime 
example of a cancer that is not associated with 
radiation. However recent data suggests excess CLL is 
present in some irradiated cohorts, but not in A-bomb 
survivors. CLL is mainly a cancer of old age and makes 
up about 50% of the spontaneous leukaemogenic 
incidences in the western developed world. Richardson 
et al. [146] suggested that CLL is erroneously 
designated as a nonradiogenic form of cancer due to its 
misdiagnosis, its rarity among Asian populations, and 
its prolonged latency of perhaps 20 years, compared 
with ~5 years for other types of leukaemia.  
 
Probably the most-favored theory of aging implicates 
free radicals and reactive oxidants in causing 
deleterious and cumulative changes to DNA, lipids and 
proteins [11]. Radiation is an exogenous source of this 
random type of damage. Harman [12] identified 
mitochondria as an endogenous cellular source of ROS. 
However, recent research suggests free radicals, such as 
the superoxide anion, may not be a cause of aging in 
some species, changes in the antioxidant capabilities of 
C. elegans did not affect the nematode’s longevity 
[147]. This raises the level of uncertainty as to the 
dominant source of aging in humans and radiation’s role 
in the process. Natural background IR produces little 
DNA base damage compared with that arising from 
mitochondrial aerobic respiration. Yet IR has the ability 
to produce cancers and non-cancer diseases at relatively 
low doses [16]. IR, especially high-LET radiation, 
produces more DSBs, clustered lesions and genomic 
instability than endogenous sources of ROS. These 
detrimental properties provide IR with the means to 
accelerate cellular senescence, critical stem cells 
included [66,  148]. However, IR’s other dominant 
deleterious effects, and hence aging mechanisms, may 
be associated with apoptosis and inflammation. A-bomb 
survivors exposed to a dose of 1 Gy lose 1.3 years of 
life and details are emerging that show premature 
increases in inflammation markers and ROS, equivalent 
to an astonishing nine years of aging [54, 137]. 
 
Not only does IR inflict damage directly to cells but 
also by, perhaps understated, indirect means. The 
importance of redox-dependent ROS and RNS signaling 
is highlighted by Ojima et al. [149] finding that DNA 
breaks caused by very low doses (1.2-5.0 mGy) are not 
found in target cells, but largely located in bystander 
cells. Radiation-induced oxidative stress not only 
disrupts intracellular signaling, but also cell-to-cell 
communication [59], perhaps accelerating an age-
dependent decline.  
 
Recent research strengthens the links between stem cell 
function and aging [150] as highlighted by a) the ability 
of tumor suppressor P16
INK4a to dampen stem cell self-
renewal; b) defects in the DNA repair of stem cells from 
progeroid individuals; c) the pernicious properties of 
cancer stem cells, and d) stem cell exhaustion that is a 
factor in T-cell and B-cell reduction and 
immunodeficiency [23, 108, 113, 123, 151]. Conversely, 
degenerative effects due to radiation or aging not 
involving stem cells are associated with the accelerated 
apoptosis of low turnover post-mitotic cells such as 
neurons and skeletal muscle.  
 
Can aging be quantified by specific measurements of 
biological, biochemical or physiological criteria? To 
date, calorie restriction (CR) is the most researched life 
lengthening process. The reduction in nutrients appears 
to inhibit the insulin and nutrient-sensing target of 
rapamycin (TOR) protein signaling pathway [152], 
whereas obesity activates it, elevating diseases that 
accompany the metabolic syndrome, such as diabetes, 
atherosclerosis and dementia. CR appears to slow aging 
and extend the mean and maximum life spans by 
lowering free-radical production and lessening DNA 
oxidative damage (e.g., 8-oxo-dG) [153]. However, its 
coveted effects are tempered by lower body temperature 
and smaller body size [154]. While CR diminishes the 
risk of carcinogenesis by lengthening the latent period, 
radiation acts  in the exact  opposite manner, causing 
excess cancers by diminishing the latent period 
[126,  155]. Similarly, while CR appears to suppress 
age-related increases in ROS, apoptosis and 
inflammation, IR generally enhances these effects 
[16, 53, 64, 65, 157].  
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scientists could take advantage of. Studies of rhesus 
monkeys and humans assigned to CR and normal diets 
suggest some common ‘biomarkers’ of aging, namely 
increased levels of plasma glucose and insulin; although 
raised levels of another biomarker, the adrenal steroid, 
dehydroepiandrosterone (DHEAS) may not be so 
general an indicator of aging [154,  156,  158]. Subtle 
effects accompany CR’s ability to retard aging 
including changes in insulin sensitivity, insulin 
signaling, neuroendocrine function and stress response. 
There appears to be no one definitive biomarker of 
aging. The age-pigment lipofuscin, telomere shortening 
and especially p16
INK4a are biomarkers that are 
relatively unexplored for IR. The present ambiguity 
concerning IR’s effect on telomeres and p16
INK4a 
warrants further research, especially given the study of 
swifts by Bize et al. [159], which demonstrated that 
both telomere length and the rate of shortening are a 




The historical reasons for rejecting any relationship 
between radiation and aging have diminished with 
contemporary epidemiological studies that find 
radiation health effects are now not limited to an excess 
risk of cancer. Epidemiological data, especially from A-
bomb survivors, on cancer and non-cancer diseases 
currently associates radiation exposure with much of the 
aging health effect spectrum, maybe more than for any 
other contaminant or progeroid syndrome. Radiation 
risks now extend to excess heart disease, stroke, 
digestive diseases and respiratory diseases. Even so, 
deaths from diabetes, infectious disease, dementia and a 
few cancers are omitted from diseases induced at low or 
moderate radiation doses that also commonly afflict the 
elderly (Table 2). Some medical disorders linked to 
metabolic syndrome (also known as the insulin 
resistance syndrome) such as diabetes, atherosclerotic 
diseases and dementia appear to be more strongly 
related to obesity and an overactive TOR nutrient 
pathway than with radiation-mediated ROS. 
Atherosclerosis and neurological disorders for example 
may result from both ROS and TOR processes. Claims 
have been made that both the ROS/inflammation and 
TOR/insulin resistance pathways can accelerate many if 
not all diseases of aging [152,  157]. In general, 
radiation-mediated aging appears to be more associated 
with free-radical damage, DSBs, apoptosis and 
inflammation rather than dysfunctional metabolic 
processes.   
 
The biological mechanisms of aging – including 
oxidation stress, chromosomal damage, apoptosis, 
senescence cells, inflammation, telomere shortening   
and stem cell exhaustion – are now much better 
understood and continue to converge with radiation’s 
biological effects. Ironically, radiation hormesis is best 
demonstrated in its ability to reduce inflammation. 
Some animal studies suggest radiation increases 
longevity. However, there is virtually no support for a 
life span extending hypothesis for A-bomb survivors 
and other exposed groups [16]. The principle weakness 
in stating unequivocally that radiation causes aging is 
similar to that whereby radiation health effects are 
disputed in general. The case is well documented for 
radiation-induced aging at high doses. Nevertheless, the 
major challenges are to better understand natural aging 
and to compellingly show that IR can induce the 
multiple symptoms of premature aging at low doses and 
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